NRP1 and neoplasm: Small interfering RNAs have also been utilized to target NRP-1, resulting in a significant reduction of the growth, angiogenesis and metastasis formation in various human tumor models, such as hepatocellular carcinoma (81, 82), acute myeloid leukemia (83), and lung cancer (41).